These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 4363772

  • 1. Hormonal responses to intravenous and oral glucose tolerance testing in a patient with a gastrinoma and a gastrojejunostomy.
    Massaro RP.
    Gastroenterology; 1974 May; 66(5):1058-62. PubMed ID: 4363772
    [No Abstract] [Full Text] [Related]

  • 2. Hypersecretion of insulin, glucagon and gastrin in a kindred with multiple adenomatosis.
    Vance JE, Kitabchi AE, Buchanan KD, Stoli RW, Hollander D, Wood FC.
    Diabetes; 1968 May; 17():299. PubMed ID: 4385088
    [No Abstract] [Full Text] [Related]

  • 3. Exaggerated intestinal glucagon and insulin responses in human subjects.
    Vance JE, Stoll RW, Fariss BL, Williams RH.
    Metabolism; 1972 May; 21(5):405-12. PubMed ID: 4401389
    [No Abstract] [Full Text] [Related]

  • 4. Effects of diphenylhydantoin upon glucose-induced insulin secretion in three patients with insulinoma.
    Hofeldt FD, Dippe SE, Levin SR, Karam JH, Blum MR, Forsham PH.
    Diabetes; 1974 Mar; 23(3):192-8. PubMed ID: 4361409
    [No Abstract] [Full Text] [Related]

  • 5. [Associated pancreatic insular infiltrations. Insulinoma, gastrinoma, glucagonoma. Clinical, biological, and anatomo-pathological data].
    Croisier JC, Croisier G, Schaison G.
    Actual Endocrinol (Paris); 1973 Mar; 13(0):15-27. PubMed ID: 4152413
    [No Abstract] [Full Text] [Related]

  • 6. Suppression and stimulation mechanisms controlling glucagon secretion in a case of islet-cell tumor producing glucagon, insulin, and gastrin.
    Tiengo A, Fedele D, Marchiori E, Nosadini R, Muggeo M.
    Diabetes; 1976 May; 25(5):408-12. PubMed ID: 5326
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Insulin secretion in the Zollinger-Ellison syndrome.
    Rehfeld JF, Lauritsen KB, Stadil F.
    Scand J Gastroenterol Suppl; 1976 May; 37():63-6. PubMed ID: 1064142
    [Abstract] [Full Text] [Related]

  • 9. Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin.
    Murray-Lyon IM, Eddleston AL, Williams R, Brown M, Hogbin BM, Bennett A, Edwards JC, Taylor KW.
    Lancet; 1968 Oct 26; 2(7574):895-8. PubMed ID: 4176152
    [No Abstract] [Full Text] [Related]

  • 10. Primary endocrine-secreting pancreatic tumors.
    Macaron C.
    Am Fam Physician; 1980 Apr 26; 21(4):94-8. PubMed ID: 6103668
    [Abstract] [Full Text] [Related]

  • 11. Carcinoid-islet cell tumors.
    Gammill SL, Weichert R, Smith SL, Font R, Ingraffia R.
    Acta Radiol Ther Phys Biol; 1973 Jun 26; 12(3):229-40. PubMed ID: 4356093
    [No Abstract] [Full Text] [Related]

  • 12. Blood levels of insulin, glucagon and gastrin following intravenous and oral glucose administration in children with simple obesity.
    Sztefko K, Rybakowa M, Szafran Z, Sucharski P, Sołtysik-Wilk E, Jaworska W.
    Endokrynol Pol; 1988 Jun 26; 39(5):253-61. PubMed ID: 3076563
    [No Abstract] [Full Text] [Related]

  • 13. Hormone-producing tumours of the pancreas.
    Giddings AE.
    Practitioner; 1975 Jun 26; 214(1284):795-800. PubMed ID: 167363
    [No Abstract] [Full Text] [Related]

  • 14. Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis.
    Vance JE, Stoll RW, Kitabchi AE, Buchanan KD, Hollander D, Williams RH.
    Am J Med; 1972 Feb 26; 52(2):211-27. PubMed ID: 4400504
    [No Abstract] [Full Text] [Related]

  • 15. Pancreatic islet cell tumors:insulinoma, gastrinoma, and glucagonoma.
    Higgins GA.
    Surg Clin North Am; 1979 Feb 26; 59(1):131-41. PubMed ID: 220743
    [No Abstract] [Full Text] [Related]

  • 16. [The hormonally active pancreatic neoplasms. Occurrence, clinical symptoms, the diagnosis and therapeutic possibilities].
    Klein CP.
    Med Klin; 1976 Feb 20; 71(8):344-9. PubMed ID: 176563
    [No Abstract] [Full Text] [Related]

  • 17. Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome.
    Mozell E, Woltering EA, O'Dorisio TM, Fletcher WS, Sinclair AJ, Hill D.
    Surg Gynecol Obstet; 1990 Jun 20; 170(6):476-84. PubMed ID: 2188384
    [Abstract] [Full Text] [Related]

  • 18. [Zollinger-Ellison syndrome and metastatic insulinoma; its response to streptozotocin].
    Agular-Parada E, Rivadeneyra-Hinojosa J, Guzman-Patraca C, Salas-Montero J, Escalante-Herrera A.
    Arch Invest Med (Mex); 1977 Jun 20; 8(1):31-8. PubMed ID: 192163
    [Abstract] [Full Text] [Related]

  • 19. [Gastric secretion analysis in the Zollinger-Ellison syndrome].
    Ottenjann R, Peters H.
    Klin Wochenschr; 1968 Aug 15; 46(16):870-4. PubMed ID: 4302464
    [No Abstract] [Full Text] [Related]

  • 20. Effect of gastrointestinal hormones on insulin and glucagon secretion.
    Creutzfeldt W, Feurle G, Ketterer H.
    N Engl J Med; 1970 May 14; 282(20):1139-41. PubMed ID: 4909197
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.